(Q52128193)

English

Patients' assessment of quality of life instruments: a randomised study of SIP, SF-36 and SEIQoL-DW in patients with amyotrophic lateral sclerosis.

scientific article published in October 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 April 2018

http://europepmc.org/abstract/MED/11676999

Patients' assessment of quality of life instruments: a randomised study of SIP, SF-36 and SEIQoL-DW in patients with amyotrophic lateral sclerosis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 April 2018

http://europepmc.org/abstract/MED/11676999

amyotrophic lateral sclerosis

0 references

0 references

quality of life

1 reference

based on heuristic

inferred from title

Gian Domenico Borasio

3

1 reference

Europe PubMed Central

PubMed publication ID

22 April 2018

http://europepmc.org/abstract/MED/11676999

author name string

Neudert C

1

1 reference

Europe PubMed Central

PubMed publication ID

22 April 2018

http://europepmc.org/abstract/MED/11676999

Wasner M

2

1 reference

Europe PubMed Central

PubMed publication ID

22 April 2018

http://europepmc.org/abstract/MED/11676999

publication date

1 October 2001

1 reference

Europe PubMed Central

PubMed publication ID

22 April 2018

http://europepmc.org/abstract/MED/11676999

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Journal of the Neurological Sciences

1 reference

Europe PubMed Central

PubMed publication ID

22 April 2018

http://europepmc.org/abstract/MED/11676999

191

1 reference

Europe PubMed Central

PubMed publication ID

22 April 2018

http://europepmc.org/abstract/MED/11676999

1-2

1 reference

Europe PubMed Central

PubMed publication ID

22 April 2018

http://europepmc.org/abstract/MED/11676999

103-109

1 reference

Europe PubMed Central

PubMed publication ID

22 April 2018

http://europepmc.org/abstract/MED/11676999

Critical review of the international assessments of health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

The quality of mercy

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

A controlled trial of recombinant methionyl human BDNF in ALS: The BDNF Study Group (Phase III)

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

The Sickness Impact Profile: Development and Final Revision of a Health Status Measure

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Amyotrophic lateral sclerosis: lessons in trial design from recent trials

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Palliative care in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Quality of life in hospice patients. A pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases a

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Development of a direct weighting procedure for quality of life domains.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Existential well-being is an important determinant of quality of life. Evidence from the McGill Quality of Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Measurement of health-related quality of life in patients with amyotrophic lateral sclerosis in clinical trials of new therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Quality of life assessment in daily clinical oncology practice: a feasibility study.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

A new short form individual quality of life measure (SEIQoL-DW): application in a cohort of individuals with HIV/AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

The ALS Health Profile Study: quality of life of amyotrophic lateral sclerosis patients and carers in Europe.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Redefining health: living with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Relationship of the Tufts Quantitative Neuromuscular Exam (TQNE) and the Sickness Impact Profile (SIP) in measuring progression of ALS. SSNJV/CNTF ALS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Development of measurement techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Quality of life in cancer patients. Who measures what?

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Quality of life in ALS is maintained as physical function declines

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Quality of life in ALS depends on factors other than strength and physical function.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Who should measure quality of life, the doctor or the patient?

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

A comparison of four quality of life instruments in cardiac patients: SF-36, QLI, QLMI, and SEIQoL.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Quality-of-life measurement in advanced cancer: assessing the individual.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900612-8

7 January 2021

Identifiers

10.1016/S0022-510X(01)00612-8

1 reference

Europe PubMed Central

PubMed publication ID

22 April 2018

http://europepmc.org/abstract/MED/11676999

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 April 2018

http://europepmc.org/abstract/MED/11676999

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52128193&oldid=1775917172"